Three isolates of zygomycetes belonging to two different genera (Rhizopus oryzae and Absidia corymbifera) were used to produce a systemic infection in neutropenic mice. On days -2, -1 and 2 h prior to infection the mice received either posaconazole (POS) at doses ranging from 20 to 80 mg/kg/day or amphotericin B (AMB) at 1 mg/kg/day. Antifungal drug efficacy was assessed by: the prolongation of survival, the percentage of infected organs (brain, lung, spleen and kidney), and the histological examination in number of infection foci and their size in brain and kidney tissues.
INTRODUCTION
Zygomycosis is a rare but highly aggressive filamentous fungal infection (4) . The clinical manifestations of zygomycosis include primary rhinocerebral, pulmonary, gastrointestinal, cutaneous or subcutaneous, or allergic disease and disseminated disease (4, 6, 7, 13) . The zygomycetes most commonly identified as etiologic agents of human diseases are Rhizopus species, Rhizomucor species, Mucor species, and Absidia species (13). The invasive zygomycosis cause angioinvasion followed by progressive, necrotic, and generally fatal infections in immunocompromised hosts, such as diabetics with ketoacidosis, neutropenic patients, patients taking corticosteroids, and subjects with burns or iron overload (4, 6, 7, 12, 13) . The standard therapy for these life-threatening infections consists of removal of the predisposing factors, widespread surgical debridement, and high doses of intravenous amphotericin B (13). Nevertheless, the aggressive therapy, mortality is often above 50% (4, 6) . It is clear that new strategies for the treatment of zygomycosis are urgently needed.
Posaconazole is a new broad-spectrum triazole with activity against many filamentous fungal pathogens, including zygomycetes (3, 8, 11, 13, 14) . Experimental infection models and clinical data showed that POS might be useful for the treatment of zygomycosis (3, 11, 14) . No data are available on the effects of POS prophylaxis against these infections. Therefore, in this study we 
MATERIALS AND METHODS
Organisms. Three clinical isolates were used in this study: Rhizopus oryzae 4570, R. oryzae 4745 and Absidia corymbifera 4535. Both isolates of R. oryzae were recovered from the sputum of two oncology patients with systemic zygomycosis, while A. corymbifera was obtained from the sputum of a patient with pulmonary zygomycosis. Isolates were stored as conidial suspensions at -80°C in 10% glycerol until used.
Antifungal drugs. For both in vitro and in vivo studies, posaconazole (POS; Schering-Plough) was prepared in polyethylene glycol 200 (Sigma). For in vitro studies, amphotericin B (AMB, Sigma) was dissolved in dimethilsulphoxide (Sigma), while for in vivo studies (Fungizone, Bristol-Myers Squibb) it was dissolved in sterile saline.
In vitro studies. MICs were determined by the CLSI broth microdilution methodology (NCCLS M38-A document) (9) . Each strain was grown on Sabouraud dextrose agar (SDA) plates at 35°C for a period of 5 days. The fungal colonies were then covered with 1 ml of sterile 0.85% saline and gently scraped with a sterile pipette. The resulting conidial suspensions were transferred to sterile tubes and heavy particles were allowed to settle. To obtain a final inoculum of approximately 10 4 CFU/ml, the conidial suspension was further adjusted by hemocytometer. The microdilution trays, containing both drugs at concentrations ranging from 0.015 to 8.0 µg/ml, were incubated at 35°C for 21-26 h. The MIC endpoint for both drugs was the lowest drug concentration that prevents any discernible growth. Each strain was tested in quintuplicate. (iii) Survival studies. In survival studies, the mice were observed through day 10 postinfection.
Deaths were recorded daily. Moribund mice were sacrificed, and their deaths were recorded as occurring on the next day. There were from 13 to 18 mice in each group.
(iv) Qualitative cultures. The mice were treated and infected as reported above. On day three postinfection, the animals were sacrificed. Brain, lung, spleen and kidney from each animal were aseptically removed and homogenized in 2 ml of sterile saline solution. Either diluted or undiluted homogenates (including the entire organ) were plated onto SDA plates. The limit of detection was 1 CFU/organ. The data are presented as percentage of infected organs (positive cultures) with respect to the total organs observed for each group (3). There were eight mice in each group.
(v) Histopathology. The mice were treated and infected as reported above. On day three postinfection, the animals were sacrificed. Brain and kidney from control and treated animals were aseptically removed, fixed in 10% neutral buffered formalin solution, embedded in paraffin, and stained with Grocott Gomori's methenamine-silver nitrate stains. For each stained section, the number and size of infection foci (clusters of hyphae) (15) were counted in 20 consecutive were compared by ANOVA with Bonferroni's correction for repeated measures. All P values < 0.05 were considered to be significant. In the experiments with R. oryzae 4745, POS was administered at 50 mg/kg/day and the mice were infected with high and low inoculum. While AMB was effective in mice infected with both inocula (P = 0.0001), POS significantly prolonged the survival only in mice infected with low inoculum (P = 0.001).
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Then, we investigated the effect of prophylaxis on qualitative cultures of four different organs.
These experiments were conducted with R. oryzae 4570 and A. corymbifera. In these studies, POS was given at 30 mg/kg/day. The results are presented in table 2. In mice infected with R. oryzae 4570, neither AMB nor POS show any potential for organ clearance. Actually, 100 % of treated animals showed to be infected in all organs tested. In the infection due to A. corymbifera, the percentage of positive organs in treated mice was generally lower than that observed in untreated controls, but the only significant difference was observed in the brain of mice treated with AMB (12.5% vs 100%, P = 0.0014).
Then, the effects of prophylaxis were further investigated in brain and kidney tissues by histological studies. In these experiments, we examined the number and size of infection foci (clusters of hyphae). As in the previous experiment, the mice were given POS at 30 mg/kg/day. The results are figure 2A and figure 3 ). AMB was active in both organs (P < 0.05). In mice infected with A. corymbifera, either drug was effective at reducing the number of infection foci with respect to the control in both organs (P < 0.05; figure 2B ).
Prophylaxes with both drugs were effective at reducing the size of foci in the kidney of mice infected with R. oryzae 4570 (P < 0.05), while neither drug was effective in the brain ( figure 2C ). In mice infected with A. corymbifera, either drug was effective at reducing the size of foci with respect to the control in both organs (P < 0.05; figure 2D ). 
DISCUSSION
In this study, we investigated the effects of POS in the prophylaxis of experimental systemic zygomycosis. The indices used to assess the outcome of infection were: (i) survival of animals; (ii) percentages of infected organs and (iii) histopathological examination measuring either the number or the size of infection foci. In terms of survival, POS was effective against A. corymbifera and one isolate of R. oryzae. However, the protective benefit of POS against R. oryzae was inoculumdependent. These results are similar to those recently found by Ibrahim et al (5) . These authors found that caspofungin improved the survival of mice with diabetic ketoacidosis infected with a small inoculum but not a large inoculum of R. oryzae.
AMB was effective against all isolates. These data are quite similar to those previously reported by rhizopodiformis, but not with R. oryzae (3).
Prophylaxis with POS was not effective in terms of organ sterilization in mice challenged with R.
oryzae: 100% of all four organs yielded positive cultures. AMB prophylaxis was also ineffective.
These results are in accordance with previous studies that showed that AMB prolonged survival of infected animals but did not clear the fungus from the organs (10). On the contrary, organ sterilization of mice given POS and infected with A. corymbifera was not a rare event. It must be noted, however, that the only significant difference between treated and control groups was found in the brain of mice treated with the polyene (12.5% vs 100% of positive cultures, respectively, P < 0.05).
It has been previously reported that intravenous inoculation of mice with zygomycetes resulted in generalized distribution of spores, particularly in the liver and spleen, whereas the development of infection foci containing hyphae occurs in brain and kidney (1, 2) . Therefore, we further investigated the effects of prophylaxis on the histopathological features of these two organs.
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Interestingly, we found that both POS and AMB were effective at reducing the number and the expansion of infection foci in the kidney of mice challenged with R. oryzae, while only AMB was effective at reducing the number, but not the size, of fungal foci in the brain. These findings seem to correlate well with the survival results, in fact all moribund mice presented clinical evidence of neurological disorders which probably represented the ultimate cause of death. Furthermore, histopathological analysis of the brain and the kidney from mice infected with A. corymbifera and prophylactically treated with either POS or AMB showed a significant reduction in the number and the expansion of infection foci with respect to the control group.
To our knowledge, this is the first study analysing the effects of POS prophylaxis in experimental infections due to zygomycetes. We found that POS is effective in infections due to A. corymbifera in terms of prolongation of survival and reduction of active infections in organs. Although beneficial effects are also observed in infections due to R. oryzae, our data confirm that this opportunistic pathogen remains difficult to manage. 
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